3 results
Approved WMOCompleted
To assess the PD, PK and safety of the Zoreline 10.8 mg goserelin subcutaneous (SC) implant.
Approved WMOCompleted
To evaluate the safety, tolerability and pharmacokinetics of ascending single and multiple doses of CH-4051.
Approved WMORecruiting
Objective: To compare pembrolizumab plus paclitaxel with or without bevacizumab to placebo plus paclitaxel with or without bevacizumab, withrespect to progression-free survival (PFS) per RECIST 1.1 as assessed by the investigator.